Spectral Diagnostics Inc. (OTCMKTS:EDTXF – Get Free Report)’s share price was down 4.9% during mid-day trading on Thursday. The stock traded as low as $0.7770 and last traded at $0.7770. 190 shares traded hands during mid-day trading, a decline of 98% from the average daily volume of 10,489 shares. The stock had previously closed at $0.8170.
Spectral Diagnostics Stock Performance
The company has a market capitalization of $217.39 million, a price-to-earnings ratio of -7.38 and a beta of 0.14. The stock’s fifty day simple moving average is $0.87 and its two-hundred day simple moving average is $0.95.
Spectral Diagnostics Company Profile
Spectral Diagnostics Inc is a Canadian medical technology company focused on improving the diagnosis and treatment of sepsis and septic shock. The company develops products designed to identify endotoxin activity, an important factor in certain severe infections and inflammatory conditions.
Its principal diagnostic product is the Endotoxin Activity Assay, a blood test intended to measure a patient’s level of endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.
Further Reading
- Five stocks we like better than Spectral Diagnostics
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for Spectral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spectral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
